citalopram and scopolamine hydrobromide

citalopram has been researched along with scopolamine hydrobromide in 14 studies

Research

Studies (14)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (7.14)	18.7374
1990's	1 (7.14)	18.2507
2000's	5 (35.71)	29.6817
2010's	6 (42.86)	24.3611
2020's	1 (7.14)	2.80

Authors

Authors	Studies
Topliss, JG; Yoshida, F	1
Lombardo, F; Obach, RS; Waters, NJ	1
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Christensen, AV; Geoffroy, M; Scheel-Krüger, J	1
Holmgren, B; Urbá-Holmgren, R	1
Egashira, N; Fujioka, M; Fujiwara, M; Iwasaki, K; Matsumoto, Y; Matsushita, M; Mishima, K; Nishimura, R; Shoyama, Y	1
Barberi, C; Danysz, W; Gravius, A; Schäfer, D; Schmidt, WJ	1
Abbasi, SH; Akhondzadeh, S; Ashrafi, M; Farokhnia, M; Khajavi, D; Modabbernia, A; Tabrizi, M	1
Anderson, WH; Catlow, JT; Felder, CC; Higgs, RE; Kuo, MS; Laksmanan, A; Li, X; Martin, AE; Nikolayev, A; Schober, DA; Tolstikov, VV; Witkin, JM	1
Lenda, T; Pałucha-Poniewiera, A; Pilc, A; Podkowa, K	1
Feng, L; Wang, G; Wang, W; Xiao, L; Yang, J; Zhou, J; Zhu, X	1
Ebrahimi-Ghiri, M; Khakpai, F; Mohammadi-Mahdiabadi-Hasani, MH; Zarrindast, MR	1

Reviews

1 review(s) available for citalopram and scopolamine hydrobromide

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

2 trial(s) available for citalopram and scopolamine hydrobromide

Article	Year
Oral scopolamine augmentation in moderate to severe major depressive disorder: a randomized, double-blind, placebo-controlled study. The Journal of clinical psychiatry, 2012, Volume: 73, Issue:11 Topics: Administration, Oral; Adolescent; Adult; Antidepressive Agents, Second-Generation; Checklist; Cholinergic Antagonists; Citalopram; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Iran; Male; Middle Aged; Personality Inventory; Psychometrics; Scopolamine; Young Adult	2012
Scopolamine augmentation of a newly initiated escitalopram treatment for major depressive disorder: study protocol for a randomized controlled trial. Trials, 2019, Jan-09, Volume: 20, Issue:1 Topics: Administration, Oral; Adolescent; Adult; Affect; Antidepressive Agents, Second-Generation; Beijing; Citalopram; Depressive Disorder, Major; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Female; Humans; Injections, Intramuscular; Male; Middle Aged; Muscarinic Antagonists; Randomized Controlled Trials as Topic; Remission Induction; Scopolamine; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Outcome; Young Adult	2019

Article

Year

Oral scopolamine augmentation in moderate to severe major depressive disorder: a randomized, double-blind, placebo-controlled study.

The Journal of clinical psychiatry, 2012, Volume: 73, Issue:11

Topics: Administration, Oral; Adolescent; Adult; Antidepressive Agents, Second-Generation; Checklist; Cholinergic Antagonists; Citalopram; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Iran; Male; Middle Aged; Personality Inventory; Psychometrics; Scopolamine; Young Adult

2012

Scopolamine augmentation of a newly initiated escitalopram treatment for major depressive disorder: study protocol for a randomized controlled trial.

Trials, 2019, Jan-09, Volume: 20, Issue:1

Topics: Administration, Oral; Adolescent; Adult; Affect; Antidepressive Agents, Second-Generation; Beijing; Citalopram; Depressive Disorder, Major; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Female; Humans; Injections, Intramuscular; Male; Middle Aged; Muscarinic Antagonists; Randomized Controlled Trials as Topic; Remission Induction; Scopolamine; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Outcome; Young Adult

2019

Other Studies

11 other study(ies) available for citalopram and scopolamine hydrobromide

Article	Year
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1. Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19 Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship	2008
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
Effect of imipramine in the "learned helplessness" model of depression in rats is not mimicked by combinations of specific reuptake inhibitors and scopolamine. Psychopharmacology, 1990, Volume: 101, Issue:3 Topics: Animals; Antidepressive Agents; Avoidance Learning; Behavior, Animal; Citalopram; Depression; Drug Synergism; Electroshock; Helplessness, Learned; Imipramine; Male; Neurotransmitter Uptake Inhibitors; Rats; Rats, Inbred Strains; Scopolamine; Thiophenes	1990
Interaction of cholinergic and dopaminergic influences on yawning behavior. Acta neurobiologiae experimentalis, 1980, Volume: 40, Issue:3 Topics: Animals; Apomorphine; Behavior, Animal; Benzofurans; Citalopram; Fluoxetine; Metergoline; Physostigmine; Propylamines; Rats; Receptors, Cholinergic; Receptors, Dopamine; Scopolamine; Spiperone	1980
Low dose citalopram reverses memory impairment and electroconvulsive shock-induced immobilization. Pharmacology, biochemistry, and behavior, 2006, Volume: 83, Issue:1 Topics: Animals; Brain Chemistry; Citalopram; Dronabinol; Electroshock; Hallucinogens; Male; Memory Disorders; Microdialysis; Muscarinic Agonists; Oxotremorine; Parasympathetic Nervous System; Rats; Rats, Wistar; Scopolamine; Selective Serotonin Reuptake Inhibitors; Tremor	2006
The role of group I metabotropic glutamate receptors in acquisition and expression of contextual and auditory fear conditioning in rats - a comparison. Neuropharmacology, 2006, Volume: 51, Issue:7-8 Topics: Acoustic Stimulation; Animals; Avoidance Learning; Citalopram; Conditioning, Classical; Diazepam; Dizocilpine Maleate; Electroshock; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Fear; Freezing Reaction, Cataleptic; Hippocampus; Long-Term Potentiation; Male; Pyridines; Quinolines; Rats; Rats, Sprague-Dawley; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Scopolamine; Thiazoles	2006
Further Evaluation of Mechanisms Associated with the Antidepressantlike Signature of Scopolamine in Mice. CNS & neurological disorders drug targets, 2017, Volume: 16, Issue:4 Topics: Animals; Antidepressive Agents; Citalopram; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Excitatory Amino Acid Antagonists; Frontal Lobe; Ketamine; Male; Metabolome; Mice, Inbred C57BL; Mice, Knockout; Morpholines; Quinoxalines; Receptor, Muscarinic M1; Receptors, AMPA; Scopolamine; Selective Serotonin Reuptake Inhibitors; TOR Serine-Threonine Kinases	2017
The involvement of monoaminergic neurotransmission in the antidepressant-like action of scopolamine in the tail suspension test. Progress in neuro-psychopharmacology & biological psychiatry, 2017, 10-03, Volume: 79, Issue:Pt B Topics: alpha-Methyltyrosine; Animals; Antidepressive Agents; Citalopram; Depressive Disorder; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Membrane Transport Modulators; Mice, Inbred C57BL; Morpholines; Motor Activity; Norepinephrine; Reboxetine; Scopolamine; Serotonin	2017
Isobolographic analysis of the antidepressant interaction in two-drug combinations of citalopram, bupropion, and scopolamine in mice. Naunyn-Schmiedeberg's archives of pharmacology, 2022, Volume: 395, Issue:7 Topics: Animals; Antidepressive Agents; Bupropion; Citalopram; Drug Combinations; Humans; Male; Mice; Mice, Inbred Strains; Scopolamine	2022